News

Oncolytics Biotech® Announces Upcoming Annual General Meeting and Second Quarter Financial Results

Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company ...

Norgine welcomes PBS listing in Australia of IFINWIL® (eflornithine) for patients with high-risk neuroblastoma (HRNB)

This news is for Australian Media only Eflornithine is now reimbursed by the government under Australia's Pharmaceutical Benefits Scheme (PBS).

KONZA Health Supports and Endorses the CMS Digital Health Ecosystem

KONZA Health supports and endorses the CMS Digital Health Ecosystem as a bold new vision to support a shared framework for data and access that empowers people, improves care, and accelerates progress ...

Equity Insider: Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, B.C., July 29, 2025 /PRNewswire/ -- Equity Insider News Commentary - The average age of cancer patients is getting younger, ...

Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, B.C., July 29, 2025 /PRNewswire/ -- Equity Insider News Commentary – ...